Site Members can sign up for company wide alerts
After a media report said that Acorda Therapeutics might be a takeover target an investigation on behalf of investors of Acorda Therapeutics Inc. (NASDAQ:ACOR) over possible breaches of fiduciary duties was announced. The investigation by a law firm is at a preliminary stage and monitors the takeover rumors. It concerns whether Acorda Therapeutics Inc, certain of its officers and dire...
You must register (for free) or login to view the entire investigation.